IMPACT OF NEW DEVICE THERAPIES IN TREATING HEART FAILURE: PACEMAKERS AND DEFIBRILLATORS

Abstract

Introduction: Heart failure (HF) is a serious condition that affects millions of people around the world, characterized by the inability of the heart to pump blood efficiently. The evolution of device therapies, such as pacemakers and defibrillators, has significantly transformed the treatment of this condition. These devices have been fundamental in improving the quality of life and survival of patients with HF. Modern pacemakers and implantable defibrillators not only help regulate the heart rhythm, but also provide additional support to the heart and reduce the risk of potentially fatal arrhythmias. Objectives: Analyze the impact of new device therapies such as pacemakers and defibrillators in the treatment of heart failure. Methodology: To obtain data, resources from the following repositories were used: Nursing Database (BDENF), Scientific Electronic Library Online (SCIELO), PubMed and Latin American Caribbean Literature in Health Sciences (LILACS). A variety of sources, including scientific articles, monographs and journals, were examined to extract pertinent information on the subject. Results and Discussions: New device therapies show substantial benefits in the treatment of heart failure. Recent studies indicate a significant reduction in mortality and hospitalizations related to heart failure, as well as improvements in patients' quality of life. The integration of these devices into clinical practice has allowed for more effective management of symptoms and a reduction in associated complications. However, the implementation of these devices must be carefully evaluated for each patient, considering factors such as cost, potential for complications and clinical suitability. Conclusion: In conclusion, the implementation of new device therapies, such as advanced pacemakers and implantable defibrillators, has provided significant advances in the treatment of heart failure. These devices not only improve cardiac function and reduce mortality, but also improve patients' quality of life. Despite the clear benefits, it is crucial to consider individualization of treatment and ongoing monitoring to maximize results. The future promises even more innovations that could transform the therapeutic approach and offer new hope for heart failure patients.